.jpg "Jack Chang, Jr., PharmD, MSCI photo")
Clinical Pharmacologist
Gilead Sciences, Inc.
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
Jack Chang, PharmD, MSCI is currently a Senior Manager in Clnical Pharmacology at Gilead Sciences. In his current role, he manages the design and conduct of Ph1-3 studies across multiple molecules and therapeutic areas encompassing HIV, COVID-19, filoviruses, emerging viruses, and hepatitis. Prior to Gilead, Dr. Chang completed his residency training at Northwestern Memorial Hospital (PGY-1), followed by fellowship training with a focus on infectious diseases pharmacotherapy at Midwestern University (PGY-2 to 4). Over his career, he has been an active scientific contributor with over 25 published peer-reviewed articles and more than 40 posters presented at national and international scientific conferences.